Rhode Island Attorney General Peter Neronha announced on Monday that the state would receive $5.4 million as its share of a $700 million settlement reached last week between consumer goods company Reckitt Benckiser and a coalition representing all 50 states over the company’s marketing of the opioid addiction treatment Suboxone. News of the settlement comes after a $1.4 billion deal between Reckitt Benckiser and the federal government to settle a similar lawsuit was announced in July.
Under the terms of the settlement, Rhode Island will receive a total of $5.4 million in settlement funds. Of that amount, $2.9 million will be returned to the State’s Medicaid administrator, the Executive Office of Health and Human Services, and the remaining $2.4 million will be returned to the federal government.
Reckitt Benckiser, a U.K.-based consumer goods corporation, had been sued by the federal government and several states for its role in the aggressive marketing practices of its former pharmaceutical division, which was spun off by the company as Indivior in 2014. Indivior also faces its own civil litigation and was indicted on criminal charges in April.
Suit Alleged Over-Prescribing of Opioids
The civil settlement includes actions by Reckitt Benckiser and its pharmaceutical division